Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockman6767on Sep 03, 2020 8:42am
106 Views
Post# 31500482

RE:+++ The 2 people they hired +++

RE:+++ The 2 people they hired +++What a joke! Is the best you can do  "with business, comes money"?  That is a meaningless phrase. You need to show us the numbers for your forecast. Show us how you calculate your "money." How much!!!  How much do expect in revenue for the Ryplasim approval if they get it any time in the next year or two. How much do they expect for the Covid involv4ement from the resale of whole blood. You present meaningless phrases. Back up what you claim!
<< Previous
Bullboard Posts
Next >>